FDA investigators audited the BioReliance - Rockville, MD, United States facility and issued 4 inspectional observations (via FDA 483) on 03 Jul 2012.
Product details
- Category: Animal Drugs & Feeds / Human Drugs
- Number of Observations: 4
- Inspection end: 03 Jul 2012
- Location: Rockville, United States
- FEI: 1122041
